Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
Sangle GV, Lauffer LM, Grieco A, Trivedi S, Iakoubov R, Brubaker PL. Sangle GV, et al. Among authors: lauffer lm. Endocrinology. 2012 Feb;153(2):564-73. doi: 10.1210/en.2011-1732. Epub 2011 Dec 20. Endocrinology. 2012. PMID: 22186413
Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell.
Mulherin AJ, Oh AH, Kim H, Grieco A, Lauffer LM, Brubaker PL. Mulherin AJ, et al. Among authors: lauffer lm. Endocrinology. 2011 Dec;152(12):4610-9. doi: 10.1210/en.2011-1485. Epub 2011 Oct 4. Endocrinology. 2011. PMID: 21971158
Essential role for protein kinase Cζ in oleic acid-induced glucagon-like peptide-1 secretion in vivo in the rat.
Iakoubov R, Ahmed A, Lauffer LM, Bazinet RP, Brubaker PL. Iakoubov R, et al. Among authors: lauffer lm. Endocrinology. 2011 Apr;152(4):1244-52. doi: 10.1210/en.2010-1352. Epub 2011 Feb 15. Endocrinology. 2011. PMID: 21325047
GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell.
Lauffer LM, Iakoubov R, Brubaker PL. Lauffer LM, et al. Diabetes. 2009 May;58(5):1058-66. doi: 10.2337/db08-1237. Epub 2009 Feb 10. Diabetes. 2009. PMID: 19208912 Free PMC article.
Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice.
Iakoubov R, Lauffer LM, Trivedi S, Kim YI, Brubaker PL. Iakoubov R, et al. Among authors: lauffer lm. Endocrinology. 2009 Sep;150(9):4033-43. doi: 10.1210/en.2009-0295. Epub 2009 Jun 4. Endocrinology. 2009. PMID: 19497974
GPR119: "double-dipping" for better glycemic control.
Lauffer L, Iakoubov R, Brubaker PL. Lauffer L, et al. Endocrinology. 2008 May;149(5):2035-7. doi: 10.1210/en.2008-0182. Endocrinology. 2008. PMID: 18427153 No abstract available.
T1R3: how to indulge the gut's sweet tooth.
Iakoubov R, Lauffer LM. Iakoubov R, et al. Among authors: lauffer lm. Am J Physiol Endocrinol Metab. 2012 Oct 1;303(7):E813-4. doi: 10.1152/ajpendo.00418.2012. Epub 2012 Aug 14. Am J Physiol Endocrinol Metab. 2012. PMID: 22895784 Free article. No abstract available.
Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
Kühnen P, Matthae R, Arya V, Hauptmann K, Rothe K, Wächter S, Singer M, Mohnike W, Eberhard T, Raile K, Lauffer LM, Iakoubov R, Hussain K, Blankenstein O. Kühnen P, et al. Among authors: lauffer lm. Clin Endocrinol (Oxf). 2014 Dec;81(6):847-54. doi: 10.1111/cen.12473. Epub 2014 May 19. Clin Endocrinol (Oxf). 2014. PMID: 24750227
Evidence for a two-step mechanism involved in assembly of functional signal recognition particle receptor.
Andrews DW, Lauffer L, Walter P, Lingappa VR. Andrews DW, et al. J Cell Biol. 1989 Mar;108(3):797-810. doi: 10.1083/jcb.108.3.797. J Cell Biol. 1989. PMID: 2537835 Free PMC article.
The beta subunit of the signal recognition particle receptor is a transmembrane GTPase that anchors the alpha subunit, a peripheral membrane GTPase, to the endoplasmic reticulum membrane.
Miller JD, Tajima S, Lauffer L, Walter P. Miller JD, et al. J Cell Biol. 1995 Feb;128(3):273-82. doi: 10.1083/jcb.128.3.273. J Cell Biol. 1995. PMID: 7844142 Free PMC article.